Literature DB >> 14613959

Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 antimicrobial agents.

Eric Hernandez1, Monique Girardet, Francoise Ramisse, Dominique Vidal, Jean-Didier Cavallo.   

Abstract

Ninety-four isolates of Yersinia pestis collected by the French army between 1964 and 1988 were evaluated for their susceptibilities to 24 antibiotics by the agar dilution method. All the isolates were susceptible to beta-lactam antibiotics including imipenem, to fluoroquinolones, aminoglycosides and to doxycycline. The most active compounds were fluoroquinolone antibiotics, third-generation cephalosporins and aminoglycosides.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14613959     DOI： 10.1093/jac/dkg484

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  14 in total

Review 1.  Resistance of Yersinia pestis to antimicrobial agents.

Authors:  Marc Galimand; Elisabeth Carniel; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

2.  Comparison of Etest method with reference broth microdilution method for antimicrobial susceptibility testing of Yersinia pestis.

Authors:  David R Lonsway; Sandra K Urich; Henry S Heine; Sigrid K McAllister; Shailen N Banerjee; Martin E Schriefer; Jean B Patel
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

3.  In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods.

Authors:  Henry S Heine; Jeremy Hershfield; Charles Marchand; Lynda Miller; Stephanie Halasohoris; Bret K Purcell; Patricia L Worsham
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

4.  In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.

Authors:  Jered M Wendte; Duraisamy Ponnusamy; Deanna Reiber; Jeffrey L Blair; Kenneth D Clinkenbeard
Journal:  Antimicrob Agents Chemother       Date:  2011-05-31       Impact factor: 5.191

5.  Lovastatin protects against experimental plague in mice.

Authors:  Saravanan Ayyadurai; Hubert Lepidi; Claude Nappez; Didier Raoult; Michel Drancourt
Journal:  PLoS One       Date:  2010-06-02       Impact factor: 3.240

6.  Levofloxacin cures experimental pneumonic plague in African green monkeys.

Authors:  Robert Colby Layton; William Mega; Jacob D McDonald; Trevor L Brasel; Edward B Barr; Andrew P Gigliotti; Frederick Koster
Journal:  PLoS Negl Trop Dis       Date:  2011-02-08

7.  Whole-animal chemical screen identifies colistin as a new immunomodulator that targets conserved pathways.

Authors:  Yun Cai; Xiou Cao; Alejandro Aballay
Journal:  mBio       Date:  2014-08-12       Impact factor: 7.867

Review 8.  Antibiotic Therapy of Plague: A Review.

Authors:  Florent Sebbane; Nadine Lemaître
Journal:  Biomolecules       Date:  2021-05-12

9.  Rapid Antibiotic Susceptibility Testing of Tier-1 Agents Bacillus anthracis, Yersinia pestis, and Francisella tularensis Directly From Whole Blood Samples.

Authors:  Shahar Rotem; Ohad Shifman; Moshe Aftalion; David Gur; Tamar Aminov; Ronit Aloni-Grinstein
Journal:  Front Microbiol       Date:  2021-07-09       Impact factor: 5.640

10.  Tandem repeats analysis for the high resolution phylogenetic analysis of Yersinia pestis.

Authors:  C Pourcel; F André-Mazeaud; H Neubauer; F Ramisse; G Vergnaud
Journal:  BMC Microbiol       Date:  2004-06-08       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.